The Celigo Image Cytometer reduces assay time while providing richer, quantitative readouts to accelerate assessment of vaccine and antiviral compound candidates.
There are many methods to determine a viral titer, with each having its pros and cons, however the increasing need to have high throughput methods to determine viral titers are ever-pressing.
Many factors and considerations must be optimized to develop the appropriate cell-based assays for gene therapy development.
Simultaneously Image and Analyze Cell Expansion and Cytotoxic Potential During Ex Vivo Manufacturing
The microneutralization assay is a powerful, high-throughput screening tool crucial to the efficient development of novel vaccines and the discovery of compounds that can prevent or treat viral disease.
Syngeneic tumor models and human immune cell-engrafted mice are two of the popular preclinical tools in immuno-oncology studies.
There is no single “one size fits all” cell-based assay however 3D cell cultures have been shown to be more physiologically relevant in oncology, immune oncology and other fields.
Between preventative vaccines and palliative treatment for the sickest COVID-19 patients lies the realm of existing drugs that could be repurposed for antiviral prophylaxis.
During this webinar, Dr. Suzanne Riches highlights a variety of approaches for conducting virology assays in a high-throughput format.
Available on demand. In this informational webinar, Dr. Dmitry Kuksin, Nexcelom Senior Scientist, examines specific virology related assays such as plaque and foci formation, as well as antibody neutralization.
Is Your Lab Using High-throughput Image Cytometry to Expedite Viral Assay Development and Research of SARS-CoV-2?
Fast track vaccine development process by conducting assays in 96- or 384-well plates based on enumeration of foci, plaque or single infected cells.